DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

156.26 -1.09 (-0.69%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $156.26 -0.69%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $156.79
Previous Close $157.35
Daily Range $155.58 - $157.97
52-Week Range $114.93 - $173.60
Market Cap $118.8B
P/E Ratio 21.23
Dividend (Yield) $3.16 (2.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,413,217
Average Daily Volume 3,357,776
Current FY EPS $9.58




Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

Amgen Inc: Why You Shouldn't Count Chickens Before They Hatch

Amgen has shelved its once-promising psoriasis drug. Should investors worry?

Investing for Beginners: How to Start in Biotech

Biotech can be tricky to learn, so we asked the experts to give their best advice to beginners. Here is what they said.

'Fast Money' Recap: Bristol-Myers' Stock Is Ailing, Health Care on the Rise

Short Sellers Get Even More Ambitious Against Biotech Leaders

Recent Buy: Amgen

PRIMECAP Sells Portions of Its Top Two Stakes

Amgen And AstraZeneca's Deal On Psoriasis Drug Faces Termination

CNBC's Stock Pops & Drops From May 26

Amgen, AstraZeneca End Development Pact; Shares Sink

Amgen's Cholesterol Fighting Drug Receives EU Approval

See More AMGN News...

AMGN's Top Competitors

AMGN $156.26 (-0.69%)
Current stock: AMGN
GILD $112.27 (-0.51%)
Current stock: GILD
CELG $114.44 (-0.43%)
Current stock: CELG
$0.00 (0.00%)
Current stock: